Nachrichten zu Agenus

Startseite > Aktien > Agenus > Nachrichten

Agenus Aktie

Aktie

ISIN: US00847G8042 WKN: A403RK SYM: AGEN Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

5,9900

USD

-0,99 %

-0,0600 USD

Letzter Kurs 02:00:00 Nasdaq

Geldkurs

19.09.24

5,9700

USD

900 STK

Briefkurs

19.09.24

6,0000

USD

700 STK

Agenus Aktie kaufen

Kauf

Verkauf

Neueste Nachrichten

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN 19.09.24 · newsfile · Agenus
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus 18.09.24 · newsfile · Agenus
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit 18.09.24 · newsfile · Agenus
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN 18.09.24 · newsfile · Agenus
Faruqi & Faruqi Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024 - AGEN 17.09.24 · newsfile · Agenus
Agenus Inc. Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the AGEN Class Action Lawsuit 17.09.24 · Business Wire (engl.) · Agenus
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN 17.09.24 · newsfile · Agenus
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN 16.09.24 · newsfile · Agenus
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus 15.09.24 · newsfile · Agenus
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN 14.09.24 · newsfile · Agenus
ROSEN, LEADING INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN 13.09.24 · newsfile · Agenus
Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024 13.09.24 · Business Wire (engl.) · Agenus

1
2
3
4
5
…
6

Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024 164 Leser
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before ... 160 Leser
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel ... 136 Leser
Faruqi & Faruqi Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff ... 120 Leser
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 116 Leser
Agenus Inc. Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the AGEN Class Action Lawsuit 116 Leser
ROSEN, LEADING INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before ... 112 Leser
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important ... 104 Leser
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus 104 Leser
Faruqi & Faruqi Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff ... 100 Leser

Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024 164 Leser
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before ... 160 Leser
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel ... 136 Leser
Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session ... 132 Leser
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have ... 132 Leser
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with ... 132 Leser
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit with the Schall Law ... 120 Leser
Rosen Law Firm Urges Agenus Inc. (NASDAQ: AGEN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights 120 Leser
Faruqi & Faruqi Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff ... 120 Leser
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 116 Leser

ESMO 2023: Agenus’ Botensilimab/Balstilimab Combination Delivers Durable Responses across Multiple Sarcoma ... 504 Leser
Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in ... 476 Leser
Agenus Announces Reverse Stock Split of Common Stock 372 Leser
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agenus Inc. - ... 360 Leser
Agenus to Participate in B. Riley Healthcare Conference 248 Leser
AGEN Investors Have Opportunity to Join Agenus Inc. Securities Fraud Investigation with the Schall ... 244 Leser
Agenus Announces Virtual Annual Shareholders Meeting 236 Leser
Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024 220 Leser
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Agenus Inc. - ... 208 Leser
Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update 204 Leser